Jeffry J. Cutrera

661 total citations
21 papers, 459 citations indexed

About

Jeffry J. Cutrera is a scholar working on Oncology, Genetics and Biotechnology. According to data from OpenAlex, Jeffry J. Cutrera has authored 21 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Genetics and 7 papers in Biotechnology. Recurrent topics in Jeffry J. Cutrera's work include Virus-based gene therapy research (8 papers), Microbial Inactivation Methods (5 papers) and CAR-T cell therapy research (4 papers). Jeffry J. Cutrera is often cited by papers focused on Virus-based gene therapy research (8 papers), Microbial Inactivation Methods (5 papers) and CAR-T cell therapy research (4 papers). Jeffry J. Cutrera collaborates with scholars based in United States and China. Jeffry J. Cutrera's co-authors include Shulin Li, Xueqing Xia, Denada Dibra, Abhisek Mitra, Arun Satelli, Eugenie S. Kleinerman, Vinod Ravi, Joseph A. Ludwig, Davis R. Ingram and Neeta Somaiah and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Hepatology.

In The Last Decade

Jeffry J. Cutrera

21 papers receiving 455 citations

Peers

Jeffry J. Cutrera

ONCOL

IMMUN

GENET

BIOTE

Alireza Labani‐Motlagh Sweden

Huajun Jin China

Wenhong Ren United States

Perpetua U. Emeagi Belgium

Xiangyi Shi China

Manuel Muñoz Spain

Cristina Mastini Italy

Xuexiang Du United States

Jianfang Ning United States

Eric Routhier United States

Alireza Labani‐Motlagh Sweden

Jeffry J. Cutrera

352 ×1.6

ONCOL

363 ×2.0

IMMUN

282 ×2.2

78 ×0.9

GENET

31 ×0.4

BIOTE

Citations per year, relative to Jeffry J. Cutrera Jeffry J. Cutrera (= 1×) peers Alireza Labani‐Motlagh

Countries citing papers authored by Jeffry J. Cutrera

Since Specialization

Citations

This map shows the geographic impact of Jeffry J. Cutrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffry J. Cutrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffry J. Cutrera more than expected).

Fields of papers citing papers by Jeffry J. Cutrera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffry J. Cutrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffry J. Cutrera. The network helps show where Jeffry J. Cutrera may publish in the future.

Co-authorship network of co-authors of Jeffry J. Cutrera

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffry J. Cutrera. A scholar is included among the top collaborators of Jeffry J. Cutrera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffry J. Cutrera. Jeffry J. Cutrera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Qingnan, Jiemiao Hu, Abhisek Mitra, et al.. (2019). Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile. Journal for ImmunoTherapy of Cancer. 7(1). 154–154. 17 indexed citations

Dibra, Denada, Abhisek Mitra, Xueqing Xia, et al.. (2016). Lack of Immunomodulatory Interleukin-27 Enhances Oncogenic Properties of Mutant p53 In Vivo. Clinical Cancer Research. 22(15). 3876–3883. 12 indexed citations

Dibra, Denada, Xueqing Xia, Abhisek Mitra, et al.. (2015). Mutant p53 in concert with an interleukin‐27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in mice. Hepatology. 63(3). 1000–1012. 29 indexed citations

Cutrera, Jeffry J., et al.. (2015). Safe and effective treatment of spontaneous neoplasms with interleukin 12 electro‐chemo‐gene therapy. Journal of Cellular and Molecular Medicine. 19(3). 664–675. 21 indexed citations

Satelli, Arun, Abhisek Mitra, Jeffry J. Cutrera, et al.. (2014). Universal Marker and Detection Tool for Human Sarcoma Circulating Tumor Cells. Cancer Research. 74(6). 1645–1650. 131 indexed citations

Cutrera, Jeffry J., et al.. (2014). Safety and Efficacy of Tumor-Targeted Interleukin 12 Gene Therapy in Treated and Non-Treated, Metastatic Lesions. Current Gene Therapy. 15(1). 44–54. 18 indexed citations

Hu, Jiemiao, Jeffry J. Cutrera, & Shulin Li. (2014). The Impact of Non-electrical Factors on Electrical Gene Transfer. Methods in molecular biology. 1121. 47–54. 6 indexed citations

Cutrera, Jeffry J., et al.. (2014). Managing Local Swelling Following Intratumoral Electro-Chemo-Gene Therapy. Methods in molecular biology. 233–239. 1 indexed citations

Cutrera, Jeffry J., et al.. (2013). Intricacies for Posttranslational Tumor-Targeted Cytokine Gene Therapy. Mediators of Inflammation. 2013. 1–9. 4 indexed citations

10.

Dibra, Denada, et al.. (2013). Abstract 1430: The role of IL27 as a driver of skin carcinogenesis.. Cancer Research. 73(8_Supplement). 1430–1430. 1 indexed citations

11.

Cutrera, Jeffry J., Blake Johnson, Lee M. Ellis, & Shulin Li. (2012). Intraosseous inoculation of tumor cells into bone marrow promotes distant metastatic tumor development: A novel tool for mechanistic and therapeutic studies. Cancer Letters. 329(1). 68–73. 4 indexed citations

12.

Dibra, Denada, Jeffry J. Cutrera, & Shulin Li. (2012). Coordination between TLR9 Signaling in Macrophages and CD3 Signaling in T Cells Induces Robust Expression of IL-30. The Journal of Immunology. 188(8). 3709–3715. 20 indexed citations

13.

Cutrera, Jeffry J., Denada Dibra, Xueqing Xia, et al.. (2011). Discovery of a Linear Peptide for Improving Tumor Targeting of Gene Products and Treatment of Distal Tumors by IL-12 Gene Therapy. Molecular Therapy. 19(8). 1468–1477. 43 indexed citations

14.

Dibra, Denada, Jeffry J. Cutrera, Xueqing Xia, & Shulin Li. (2011). WSX1 Expression in Tumors Induces Immune Tolerance via Suppression of Effector Immune Cells. PLoS ONE. 6(4). e19072–e19072. 8 indexed citations

15.

Dibra, Denada, Jeffry J. Cutrera, Xueqing Xia, et al.. (2011). Interleukin-30: A novel antiinflammatory cytokine candidate for prevention and treatment of inflammatory cytokine-induced liver injury. Hepatology. 55(4). 1204–1214. 38 indexed citations

16.

Cutrera, Jeffry J., et al.. (2010). Bleomycin/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogs. Cancer Gene Therapy. 17(7). 457–464. 24 indexed citations

17.

Cutrera, Jeffry J., et al.. (2009). Enhancement of reporter gene detection sensitivity by insertion of specific mini-peptide-coding sequences. Cancer Gene Therapy. 17(2). 131–140. 5 indexed citations

18.

Dibra, Denada, Jeffry J. Cutrera, Xueqing Xia, Mark Birkenbach, & Shulin Li. (2009). Expression of WSX1 in Tumors Sensitizes IL-27 Signaling-Independent Natural Killer Cell Surveillance. Cancer Research. 69(13). 5505–5513. 25 indexed citations

19.

Cutrera, Jeffry J., et al.. (2008). Administering Plasmid DNA Encoding Tumor Vessel–anchored IFN-α for Localizing Gene Product Within or Into Tumors. Molecular Therapy. 16(5). 901–906. 16 indexed citations

20.

Cutrera, Jeffry J., et al.. (2008). Intratumoral Bleomycin and IL-12 Electrochemogenetherapy for Treating Head and Neck Tumors in Dogs. Methods in molecular biology. 423. 319–325. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact